Cure-all claims for marijuana up in smoke?

Despite the fanfare, the medical benefits of marijuana remain experimental for many conditions

Cure-all claims for marijuana up in smoke?Many Canadians can hardly wait for the day the recreational use of marijuana becomes legal. As a medical doctor, I'm far less enthusiastic. I worry about two things: the experimental nature of marijuana in medical practice and the public health consequences of legalized marijuana. Before you write me off as overly prudish or an anti-marijuana…

Over-medicating to manage behaviour is damaging and wasteful

It’s time to talk about the overuse of antipsychotics among adults with developmental disabilities

Over-medicating to manage behaviour is damaging and wastefulBy Yona Lunsky University of Toronto and Tara Gomes St. Michael’s Hospital Inappropriate prescribing of antipsychotic medications – drugs like Risperdal, Zyprexa and Abilify – to seniors, especially those in long-term care with conditions like dementia, has been a hot topic across Canada in recent years. We’ve also increasingly heard about the high numbers of these medications…

We must rethink our approach to battling opioid abuse

As fentanyl deaths continue to rise, we cannot continue to pretend that we are on the path to solving this problem

We must rethink our approach to battling opioid abuseBy Gabriela Novotna and Tom McIntosh University of Regina Thirteen Canadians a day were hospitalized for an opioid overdose in 2014-2015, according to the Canadian Institute of Health Information (CIHI), and the rate of opioid poisoning  hospitalizations has been steadily rising. What began with the over-prescription of opioids such as OxyContin, a painkiller once thought to…

Catastrophic pharmacare is a catastrophe

Why the provinces don’t need $3 billion in federal tax dollars for flawed prescription drug policies

Catastrophic pharmacare is a catastropheLast week, the CD Howe Institute called on Ottawa to give provinces nearly $3-billion to establish national standards for catastrophic drug coverage and to mandate a system of transparent price negotiations with pharmaceutical drug manufacturers. Acting on those recommendations would represent a major step backward for Canada, one that would cost Canadians billions of dollars…